120 related articles for article (PubMed ID: 32314875)
21. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ
Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405
[TBL] [Abstract][Full Text] [Related]
22. Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma.
Kaptein FHJ; Stals MAM; Kapteijn MY; Cannegieter SC; Dirven L; van Duinen SG; van Eijk R; Huisman MV; Klaase EE; Taphoorn MJB; Versteeg HH; Buijs JT; Koekkoek JAF; Klok FA
J Thromb Haemost; 2022 Jul; 20(7):1665-1673. PubMed ID: 35460331
[TBL] [Abstract][Full Text] [Related]
23. Intracranial Hemorrhage in Patients with Anticoagulant Therapy Undergoing Stereotactic Radiosurgery for Brain Metastases: A Bi-Institutional Analysis.
Ehret F; Kaul D; Mose L; Budach V; Vajkoczy P; Fürweger C; Haidenberger A; Muacevic A; Mehrhof F; Kufeld M
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158734
[TBL] [Abstract][Full Text] [Related]
24. Treat the VTE and worry less about the hemorrhage: A sigh of relief or is the jury still out for therapeutic anticoagulation in high-grade glioma?
Taylor JW
Neuro Oncol; 2022 Mar; 24(3):465-466. PubMed ID: 34850168
[No Abstract] [Full Text] [Related]
25. Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review.
Cai Q; Zhang X; Chen H
Thromb J; 2021 Nov; 19(1):93. PubMed ID: 34838069
[TBL] [Abstract][Full Text] [Related]
26. Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis.
Frere C; Font C; Esposito F; Crichi B; Girard P; Janus N
Support Care Cancer; 2022 Apr; 30(4):2919-2931. PubMed ID: 34617159
[TBL] [Abstract][Full Text] [Related]
27. Current status of treatment of cancer-associated venous thromboembolism.
Xiong W
Thromb J; 2021 Mar; 19(1):21. PubMed ID: 33789658
[TBL] [Abstract][Full Text] [Related]
28. Impaired contraction of blood clots precedes and predicts postoperative venous thromboembolism.
Evtugina NG; Peshkova AD; Pichugin AA; Weisel JW; Litvinov RI
Sci Rep; 2020 Oct; 10(1):18261. PubMed ID: 33106547
[TBL] [Abstract][Full Text] [Related]
29. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
[TBL] [Abstract][Full Text] [Related]
30. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
Zwicker JI; Karp Leaf R; Carrier M
J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
[TBL] [Abstract][Full Text] [Related]
31. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review.
Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R
J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517
[TBL] [Abstract][Full Text] [Related]
32. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Jo J; Donahue J; Sarai G; Petroni G; Schiff D
Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
[TBL] [Abstract][Full Text] [Related]
33. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Rojas-Hernandez CM; Oo TH; García-Perdomo HA
J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
[TBL] [Abstract][Full Text] [Related]
34. The risk of intracranial hemorrhage in glioma patients receiving anticoagulant treatment for venous thromboembolism: a bayesian network meta-analysis.
Huo H; Shen S; Yang Y; Zhang H; Wu S; Bi T; Li Y
J Thromb Thrombolysis; 2023 Aug; 56(2):333-341. PubMed ID: 37341895
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
